ERBB2 and breast cancer: In a separate study by Griguolo et al. [81] a higher proportion of CD4 + FoxP3 + /CD8 + cells within the HR + /HER2–metastatic tumor stroma was linked with worse outcomes in different breast cancer subtypes.